Seres Therapeutics, Inc.

MCRB · XNAS

CIK 1609809fmd_1N3RTF70SV8EPT2Q4WGTAEPB6BManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

Ratios computed from the standardized statements. Select a value to open its proof.